Opthea Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Opthea Stock Forecast and Price Target
The average price target of $0.70 for Opthea's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 12.9% from the last closing price in May, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $1.69 and a low estimate of $0.30. If you're considering investing in OPT stock, it's essential to look at its competitors, too.
12.90% Upside
Opthea Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Opthea's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $0.63, which would mean an increase of 100.00%. Over the next seven years, experts predict that Opthea's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CSL Stock Forecast | CSL | Outperform |
12
|
$275.80 | Buy/Sell | $205.51 | -26.34% |
| TLX Stock Forecast | Telix Pharmaceuticals | Buy |
6
|
$15.24 | Buy/Sell | $13.37 | -4.86% |
| NEU Stock Forecast | Neuren Pharmaceuticals | Buy |
11
|
$19.70 | Buy/Sell | $26.43 | 34.92% |
| PNV Stock Forecast | PolyNovo | Outperform |
8
|
$2.09 | Buy/Sell | $1.88 | 2.39% |
| CUV Stock Forecast | Clinuvel Pharmaceuticals | Buy |
16
|
$14.86 | Buy/Sell | $27.41 | 49.73% |
Opthea Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Opthea's Revenue has grown by 160.00%, rising from $150.00k to $390.00k. For next year, analysts predict Revenue of $520.00k, which would mean an increase of 33.33%. Over the next seven years, experts predict that Opthea's Revenue will grow at a rate of 101869.23%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IMU Stock Forecast | Imugene | Buy |
4
|
$0.08 | Buy/Sell | $0.35 | 425.00% |
| IMM Stock Forecast | Immutep | Buy |
8
|
$0.44 | Buy/Sell | $1.26 | 127.27% |
| MSB Stock Forecast | Mesoblast | Buy |
9
|
$1.09 | Buy/Sell | $0.69 | 0.92% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PYC Stock Forecast | PYC Therapeutics | Buy |
8
|
$0.11 | Buy/Sell | $0.30 | 227.27% |
| CGS Stock Forecast | Cogstate | Buy |
11
|
$1.40 | Buy/Sell | $1.85 | 28.57% |
| BOT Stock Forecast | Botanix Pharmaceuticals | - |
0
|
$0.19 | Buy/Sell | $0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DXB Stock Forecast | Dimerix |
0
|
$0.36 | Buy/Sell | $0.00 | 61.11% | |
| ACW Stock Forecast | Actinogen Medical |
5
|
$0.03 | Buy/Sell | $0.15 | -100.00% | |
| BIT Stock Forecast | Biotron | - |
0
|
$0.05 | Buy/Sell | $0.00 | -100.00% |
Opthea EBITDA Forecast for 2023 - 2025 - 2030
Opthea's EBITDA has grown In the last three years, rising from $-25.36M to $-150.01M – a growth of 491.52%. In the next year, analysts believe that EBITDA will reach $-216.28M – an increase of 44.18%. In 2030, professionals predict that Opthea's EBITDA will decrease by 5.07%, reaching $-142.40M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SPL Stock Forecast | Starpharma Holdings | - |
8
|
$0.12 | Buy/Sell | $0.95 | -100.00% |
| IVX Stock Forecast | Invion | - |
0
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| PTX Stock Forecast | Prescient Therapeutics |
2
|
$0.05 | Buy/Sell | $0.20 | 180.00% |
Opthea EBIT Forecast for 2023 - 2025 - 2030
Opthea's EBIT has seen impressive growth In the last three years, rising from $-25.38M to $-150.03M – a growth of 491.13%. In the next year, analysts believe that EBIT will reach $-222.78M – an increase of 48.49%. By 2030, professionals believe that Opthea's EBIT will have decreased by 1110.89%, falling to $1.52B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CYP Stock Forecast | Cynata Therapeutics |
0
|
$0.24 | Buy/Sell | $1.24 | 416.67% | |
| 1AI Stock Forecast | Algorae Pharmaceuticals | - |
-4
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| IMC Stock Forecast | Immuron | - |
0
|
$0.07 | Buy/Sell | $0.00 | -100.00% |
Opthea EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Opthea's EPS has grown by 100.00%, rising from $-0.10 to $0.00. For next year, analysts predict EPS of $-0.45, which would mean an increase of 100.00%. Over the next seven years, experts predict that Opthea's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATH Stock Forecast | Alterity Therapeutics | - |
0
|
$0.00 | Buy/Sell | $0.75 | 0.00% |
| GTG Stock Forecast | Genetic Technologies | - |
0
|
$0.12 | Buy/Sell | $1.00 | -100.00% |
| OSL Stock Forecast | OncoSil Medical | - |
0
|
$0.01 | Buy/Sell | $0.11 | -100.00% |
.jpg)